Post-ADT PSA kinetics predict survival
نویسندگان
چکیده
منابع مشابه
ADT ADT ADT VMM Refinement memories ADT refinement ADTs
In this paper we present our novel power exploration methodology for applications with dynamic data types. Our methodology is crucial to obtain eeective solutions in an embedded (HW or SW) processor context. The contributions are twofold. First we deene the complete search space for Virtual Memory Management (VMM) mechanisms in a struc-tured way with orthogonal decision trees. Secondly we prese...
متن کاملAntioxidants therapy: An alternative for androgen deprivation therapy (ADT) to decrease prostate-specific antigen (PSA) level
Prostate cancer is a complex, heterogeneous and multifactorial disease. The high prevalence of prostatitis could contribute to prostate carcinogenesis, which is the second most common cause of cancer-related death in males. Unfavorable metabolic profiles such as hormonal imbalances, oxidative stress and inflammation in prostate disorders are associated with several complications. Different stra...
متن کاملDifferentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics.
Prostate-specific antigen (PSA) testing for the early diagnosis of prostate cancer has led to a decrease in cancer mortality. However, the high prevalence of low-grade prostate cancer and its long natural history, competing causes of death in older men and treatment patterns of prostate cancer, have led to dramatic overtreatment of the disease. Improved markers of prostate cancer lethality are ...
متن کاملCinétique du PSA après prostatectomie totale PSA kinetics after total prostatectomy
The prostate specific antigen (PSA) is the best marker of the prostate cancer today although not very specific of this pathology. The dynamic interpretation of this marker always has to prevail over that of overtaking a threshold. With the lack of residual cancer, PSA becomes undetectable by the first month after total prostatectomy: less than 0,1 μg/L. The type of diminution monoor biphasic of...
متن کاملTime to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.
BACKGROUND The objective of this study was to evaluate the relation between the kinetics of prostate-specific antigen (PSA) decline after the initiation of androgen-deprivation therapy (ADT) and overall survival (OS) in men with metastatic, hormone-sensitive prostate cancer (HSPC). METHODS The authors' institutional database was used to identify a cohort of men with metastatic HSPC who were t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Urology
سال: 2009
ISSN: 1759-4812,1759-4820
DOI: 10.1038/nrurol.2009.32